JPMorgan Chase & Co. Reiterates “€26.00” Price Target for Evonik Industries (EVK)

JPMorgan Chase & Co. set a €26.00 ($30.23) price objective on Evonik Industries (FRA:EVK) in a research report released on Tuesday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

Several other equities analysts have also commented on EVK. Goldman Sachs Group set a €28.20 ($32.79) price objective on shares of Evonik Industries and gave the company a neutral rating in a research report on Tuesday. Baader Bank set a €32.00 ($37.21) price objective on shares of Evonik Industries and gave the company a buy rating in a research report on Tuesday. Deutsche Bank set a €40.00 ($46.51) price objective on shares of Evonik Industries and gave the company a buy rating in a research report on Tuesday, April 2nd. UBS Group set a €23.00 ($26.74) price objective on shares of Evonik Industries and gave the company a sell rating in a research report on Thursday, April 11th. Finally, DZ Bank reiterated a buy rating on shares of Evonik Industries in a research report on Wednesday, March 13th. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and ten have assigned a buy rating to the company’s stock. Evonik Industries presently has a consensus rating of Hold and an average price target of €30.93 ($35.96).

EVK stock opened at €26.01 ($30.24) on Tuesday. Evonik Industries has a 52 week low of €26.78 ($31.14) and a 52 week high of €32.97 ($38.34).

Evonik Industries Company Profile

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.

Further Reading: What does cost of debt say about a company’s financial health?

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.